Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07452588

Effect of Sodium Chloride 5% Solution as an Adjuvant Treatment With Antimicrobial Therapy in the Treatment of Bacterial Infectious Keratitis

This study aims to detect the effect of sodium chloride 5% solution as an adjuvant treatment with antimicrobial therapy in treatment of bacterial infectious keratits and to assess whether NaCl 5% accelerates epithelial healing, improves microbial eradication, and enhances visual outcomes in bacterial infectious keratitis.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Prospective randomized control study to detect the effect of sodium chloride 5% solution as an adjuvant treatment with antimicrobial therapy in treatment of bacterial infectious keratits and to assess whether NaCl 5% accelerates epithelial healing, improves microbial eradication, and enhances visual outcomes in bacterial infectious keratitis.Data study will include two groups classified as follow : the first group will include treatment of microbial keratitis by antibiotic with sodium chloride 5% , the second group will include treatment by antibiotic only

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

IncluInclusion Criteria

  • Age ≥ 18 years.
  • Clinically diagnosed bacterial infectious keratitis
  • Positive corneal scraping or strong clinical suspicion of bacterial cause.
  • Ability to provide informed consent and attend follow-up visits

Exclusion criteria

  • • Fungal, viral, or acanthamoeba keratitis.
  • Recent (<7 days) topical corticosteroid use.
  • Corneal perforation or impending perforation.
  • History of hypersensitivity to study agents.
  • Systemic immunocompromised state (uncontrolled diabetes, Human immune defecinicy virus).
  • Poor compliance expected with follow-up.

Treatment and study plan

Sodium chloride 5% solution

Drug

Use Sodium chloride 5% solution with usual anti microbial drugs

quinolones

Drug

Use of usual topical anti microbial treatment only

Primary outcomes

  1. Control of infection

    Time frame: 6 months

    Improvement of manifestation according to rate of healing

Study contacts

Contact information is provided by the study sponsor or research team.

Amr Mounir Mohamed, Assistant professor

CONTACT

01005026170

Nancy Safwat Kaldas, Specialist

CONTACT

[email protected]

01200933440

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Acronym: keratitis

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Mar 5, 2026
Registry last updated
Mar 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.